| Dr Jill Yvonne Carlson, MD | |
|
659a Main St, Laurel, MD 20707-4067 | |
| (443) 621-3554 | |
| Not Available |
| Full Name | Dr Jill Yvonne Carlson |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 659a Main St, Laurel, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558324517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | D0052673 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jill Yvonne Carlson, MD 659a Main St, Laurel, MD 20707-4067 Ph: (443) 621-3554 | Dr Jill Yvonne Carlson, MD 659a Main St, Laurel, MD 20707-4067 Ph: (443) 621-3554 |
News Archive
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted priority review for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of Hereditary Angioedema (HAE).
A curious twist in a family of plant proteins called chalcone-isomerase recently was discovered by Salk Institute for Biological Studies scientist Joseph Noel and colleagues at Iowa State University led by Eve Wurtele.
Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.
› Verified 3 days ago
Ayesha Hasan Khan, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 14201 Laurel Park Dr Ste 215, Laurel, MD 20707 Phone: 240-690-2828 | |
Dr. Jemima Kankam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13639 Baltimore Avenue, Laurel, MD 20707 Phone: 301-604-4830 Fax: 301-604-4929 | |
Kennedy N Kwende, NP Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9117 Sumner Grove Dr, Laurel, MD 20708 Phone: 240-393-3602 | |
Dr. Sally Anne Willett, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 585 Main Street, Suite 143, Laurel, MD 20707 Phone: 301-490-0778 Fax: 301-498-4663 | |
Cholet Kelly Josue, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14201 Laurel Park Dr Ste 221, Laurel, MD 20707 Phone: 312-491-0183 | |
Lisa Ann Burgess, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3514 Sharonwood Rd, Apt 2c, Laurel, MD 20724 Phone: 443-804-6886 | |
Dr. Chad Jason Lennon, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9771 Tiger Lily Path, Apt. 3b, Laurel, MD 20723 Phone: 917-669-6237 |